---

A comprehensive review on preliminary screening models for the evaluation of anti-cancer agents

Full Text PDF Share on Facebook Share on Twitter

---

Review Article

Author Details : Bhargav K Kamani, Keval Y. Raval*

Volume : 8, Issue : 1, Year : 2023

Article Page : 27-31

https://doi.org/10.18231/j.ijcaap.2023.004

Suggest article by email

Get Permission

Abstract

Cancer refers to a category of illnesses characterised by uncontrolled growth of new cells. The screening of an anticancer drug is a time-consuming procedure that requires several in-vitro, in-vivo, and clinical investigations. Toxic dosages of screening pharmaceutical drugs in-vivo at varying concentrations need to be envisioned in order to prevent chemical poisoning in animals throughout an experiment. Cancer management has been the subject of several in-vitro and in-vivo investigations. To determine the test compound's anti-cancer efficacy, this research compiled a review of in vivo and in vitro assays. Here, the study emphasizes on the numerous preclinical approaches and processes used in anticancer research.
 

Keywords: Cancer, In­vivo, in­vitro, Anti­cancer drug, Screening methods

How to cite : Kamani B K, Raval K Y, A comprehensive review on preliminary screening models for the evaluation of anti-cancer agents. IP Int J Compr Adv Pharmacol 2023;8(1):27-31

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.